← Back to Analyst Consensus 
ANRO Buy
Alto Neuroscience, Inc.
Current Price —
Implied Upside —
Analysts 17
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 1 reiterations from 1 firms
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 19, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Aug 17, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Aug 13, 2026 | Wedbush | maintain | Neutral → Neutral | — | 58% |
| Aug 13, 2026 | BTIG | maintain | Buy → Buy | — | 52% |
| May 18, 2026 | Baird | maintain | Outperform → Outperform | — | 55% |
| May 14, 2026 | Wedbush | maintain | Neutral → Neutral | — | 58% |
| May 11, 2026 | HC Wainwright& Co. | reiterate | Buy → Buy | — | — |
| May 11, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Apr 22, 2026 | Chardan Capital | maintain | Buy → Buy | — | 47% |
| Apr 2, 2026 | Baird | maintain | Outperform → Outperform | — | 55% |
| Apr 2, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Apr 2, 2026 | Jones Trading | maintain | Buy → Buy | — | 50% |
| Apr 2, 2026 | Wedbush | maintain | Neutral → Neutral | — | 58% |
| Apr 2, 2026 | Chardan Capital | maintain | Buy → Buy | — | 47% |
| Mar 18, 2026 | Baird | maintain | Outperform → Outperform | — | 55% |
| Mar 17, 2026 | Chardan Capital | maintain | Buy → Buy | — | 47% |
| Mar 17, 2026 | Wedbush | maintain | Neutral → Neutral | — | 58% |
| Feb 17, 2026 | BTIG | maintain | Buy → Buy | $28 | 52% |
| Jan 5, 2026 | Chardan Capital | maintain | Buy → Buy | $30 | 47% |
| Nov 17, 2025 | BTIG | initiate | — → Buy | $27 | 52% |
| Nov 13, 2025 | Baird | maintain | Outperform → Outperform | $22 | 55% |
| Nov 12, 2025 | Jefferies | maintain | Buy → Buy | $25 | 52% |
| Oct 24, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $50 | 44% |
| Oct 20, 2025 | Baird | maintain | Outperform → Outperform | $16 | 55% |
| Sep 29, 2025 | Chardan Capital | initiate | — → Buy | $15 | 47% |
| Aug 18, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| Jun 26, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| May 15, 2025 | Wedbush | reiterate | Neutral → Neutral | $4 | 58% |
| Apr 7, 2025 | HC Wainwright & Co. | initiate | — → Buy | $10 | 44% |
| Dec 16, 2024 | Jones Trading | initiate | — → Buy | $18 | 50% |
| Nov 13, 2024 | Stifel | maintain | Buy → Buy | $10 | 53% |
| Oct 23, 2024 | Wedbush | downgrade | Outperform → Neutral | $4 | 58% |
| Oct 23, 2024 | Baird | maintain | Outperform → Outperform | $10 | 55% |
| Sep 10, 2024 | Wedbush | reiterate | Outperform → Outperform | $29 | 58% |
| Sep 3, 2024 | Wedbush | initiate | — → Outperform | $29 | 58% |
| Jun 21, 2024 | Rodman & Renshaw | initiate | — → Buy | $43 | 40% |
| Mar 25, 2024 | Stifel | reiterate | Buy → Buy | $32 | 53% |
| Feb 27, 2024 | Stifel | initiate | — → Buy | $32 | 53% |
| Feb 27, 2024 | Jefferies | initiate | — → Buy | $33 | 52% |
| Feb 27, 2024 | Baird | initiate | — → Outperform | $32 | 55% |
Price Target Trend
Mar 26, 2026 Oct 26, 2026
EPS Estimates
+1q —
0y —
0q —
+1y —
Cross-Platform Signals
No cross-platform signals in the last 90 days